Emtricitabine indications and usage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Emtricitabine}} {{CMG}}; {{AE}} {{AZ}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect") |
Gerald Chi (talk | contribs) |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Indications and Usage== | |||
EMTRIVA® is indicated in combination with other antiretroviral agents for the treatment of [[HIV-1]] infection. | |||
Additional important information regarding the use of EMTRIVA for the treatment of HIV-1 Infection. | |||
EMTRIVA should not be coadministered with ATRIPLA®, COMPLERA®, STRIBILD™, TRUVADA®, or lamivudine-containing products. | |||
In treatment-experienced patients, the use of EMTRIVA should be guided by laboratory testing and treatment history.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = EMTRIVA (EMTRICITABINE) CAPSULE EMTRIVA (EMTRICITABINE) SOLUTION [GILEAD SCIENCES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6599395-3944-44f9-97f2-e0424c6b6a1f#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 16:36, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications and Usage
EMTRIVA® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Additional important information regarding the use of EMTRIVA for the treatment of HIV-1 Infection.
EMTRIVA should not be coadministered with ATRIPLA®, COMPLERA®, STRIBILD™, TRUVADA®, or lamivudine-containing products.
In treatment-experienced patients, the use of EMTRIVA should be guided by laboratory testing and treatment history.[1]
References
Adapted from the FDA Package Insert.